These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10816681)
81. Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Kiefer F; Jiménez-Arriero MA; Klein O; Diehl A; Rubio G Addict Biol; 2008 Mar; 13(1):124-9. PubMed ID: 17573782 [TBL] [Abstract][Full Text] [Related]
82. Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability. Turel AP; Oh KH; Zagon IS; McLaughlin PJ J Clin Psychopharmacol; 2015 Oct; 35(5):609-11. PubMed ID: 26203498 [No Abstract] [Full Text] [Related]
83. Severe opioid withdrawal syndrome after a single dose of nalmefene. Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241 [No Abstract] [Full Text] [Related]
84. Barriers to the use of medications to treat alcoholism. Mark TL; Kranzler HR; Poole VH; Hagen CA; McLeod C; Crosse S Am J Addict; 2003; 12(4):281-94. PubMed ID: 14504021 [TBL] [Abstract][Full Text] [Related]
85. DSM IV axis II traits can influence compliance to treatment with oral naltrexone: a preliminary study on 30 opiate dependent patients. Streel E; Chenut C; Papageorgiou C; Verbanck P Addict Behav; 2014 Jan; 39(1):321-4. PubMed ID: 24090623 [TBL] [Abstract][Full Text] [Related]
86. Use of pure opioid antagonists for management of opioid-induced pruritus. Miller JL; Hagemann TM Am J Health Syst Pharm; 2011 Aug; 68(15):1419-25. PubMed ID: 21785031 [TBL] [Abstract][Full Text] [Related]
87. Severe uncontrolled pain in buttock in a patient on naltrexone: a diagnostic challenge. Graham JM; Evans B Anaesth Intensive Care; 2005 Dec; 33(6):808-11. PubMed ID: 16398390 [TBL] [Abstract][Full Text] [Related]
88. [Naltrexone and opioids – a painful interaction]. Kolberg ES; Madsen TOS; Roland PH Tidsskr Nor Laegeforen; 2020 Oct; 140(15):. PubMed ID: 33118781 [No Abstract] [Full Text] [Related]
89. Narcotic antagonist treatment of the criminal justice patient-institutional vs outpatient-including a 24 hour detox naltrexone induction regimen with oral medication. Brahen L; Wiechert V; Capone T NIDA Res Monogr; 1976 Sep; (9):93-8. PubMed ID: 794727 [No Abstract] [Full Text] [Related]
90. Treatment of post-burn pruritus - A systematic review and meta-analysis. Andrade LF; Abdi P; Kooner A; Eldaboush AM; Dhami RK; Natarelli N; Yosipovitch G Burns; 2024 Mar; 50(2):293-301. PubMed ID: 38097439 [TBL] [Abstract][Full Text] [Related]
91. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. McRae CA; Prince MI; Hudson M; Day CP; James OF; Jones DE Gastroenterology; 2003 Aug; 125(2):591-6. PubMed ID: 12891561 [TBL] [Abstract][Full Text] [Related]
92. Nalmefene and pruritus. Harrison PV J Am Acad Dermatol; 1990 Sep; 23(3 Pt 1):530. PubMed ID: 2212165 [No Abstract] [Full Text] [Related]
93. Naltrexone for severe self-harm behavior: a case report. Agarwal LJ; Berger CE; Gill L Am J Psychiatry; 2011 Apr; 168(4):437-8. PubMed ID: 21474600 [No Abstract] [Full Text] [Related]
94. Pathological gambling. Current status and new treatments. Kim SW; Grant JE; Grosz RL Minn Med; 2002 Jul; 85(7):48-50, 52. PubMed ID: 12152529 [TBL] [Abstract][Full Text] [Related]
95. Low-Dose Naltrexone: A Possible Option for Fibromyalgia. Irwin M; Winter S Am Fam Physician; 2024 Feb; 109(2):105. PubMed ID: 38393784 [No Abstract] [Full Text] [Related]